Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Associated-dysfunction Steatohepatitis (MASH)”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Not applicableLooking for participantsNCT06813508
What this trial is testing

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated Steatohepatitis+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06588699
What this trial is testing

Digoxin In NASH (CODIN)

Who this might be right for
NASHNAFLDMASH - Metabolic Dysfunction-Associated Steatohepatitis+5 more
Yale University 144
Testing effectiveness (Phase 2)Looking for participantsNCT06920043
What this trial is testing

Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis
Boston Pharmaceuticals 42
Post-approval studies (Phase 4)Looking for participantsNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Testing effectiveness (Phase 2)Looking for participantsNCT07145151
What this trial is testing

UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis (MASH)
The United Bio-Technology (Hengqin) Co., Ltd. 156
Post-approval studies (Phase 4)Looking for participantsNCT07249788
What this trial is testing

Resmiterom Efficacy & Safety in Patients With MASH

Who this might be right for
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Nabiqasim Industries (Pvt) Ltd 165
Testing effectiveness (Phase 2)Study completedNCT06342947
What this trial is testing

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Who this might be right for
NASHMASHMetabolic Dysfunction-Associated Steatohepatitis+1 more
Aligos Therapeutics 102
Not applicableNot Yet RecruitingNCT07332611
What this trial is testing

Long Term Prediction of MASH-related HCC Risk by Proteomics

Who this might be right for
MASH-related HCC
University Hospital, Bordeaux 30
Early research (Phase 1)Active Not RecruitingNCT05395481
What this trial is testing

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Eli Lilly and Company 176
Large-scale testing (Phase 3)Looking for participantsNCT07221227
What this trial is testing

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 1,200
Testing effectiveness (Phase 2)Study completedNCT04906421
What this trial is testing

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease
Sagimet Biosciences Inc. 168
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07276204
What this trial is testing

Betaine vs. Placebo for Serologically Diagnosed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Southern California Institute for Research and Education 70
Not applicableLooking for participantsNCT06824974
What this trial is testing

To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients

Who this might be right for
Liver Cancer, AdultMASH - Metabolic Dysfunction-Associated SteatohepatitisObesity and Overweight
University of California, San Diego 50
Testing effectiveness (Phase 2)Study completedNCT03938246
What this trial is testing

Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Sagimet Biosciences Inc. 142
Not applicableStudy completedNCT06741111
What this trial is testing

A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH)
Novo Nordisk A/S 1,233,970
Not applicableNot Yet RecruitingNCT06986447
What this trial is testing

Assessment of Non-Invasive Testing in Major Liver-Related Outcomes

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more
HRI-MAIL-NIT 1,689
Early research (Phase 1)Looking for participantsNCT06836609
What this trial is testing

Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis
Regeneron Pharmaceuticals 100
Not applicableLooking for participantsNCT06661655
What this trial is testing

Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

Who this might be right for
Metabolic Syndrome XFatty LiverMASH - Metabolic Dysfunction-Associated Steatohepatitis+4 more
E-Scopics 120
Not applicableLooking for participantsNCT06138821
What this trial is testing

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Who this might be right for
ObesityLiver DiseasesLiver Fibrosis+16 more
Pichamol Jirapinyo, MD, MPH 132
Post-approval studies (Phase 4)Looking for participantsNCT06374875
What this trial is testing

Fibrosis Lessens After Metabolic Surgery

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Non-Alcoholic Fatty Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)+2 more
Ali Aminian 120
Load More Results